Study of 608 for non-radiographic axial spondyloarthritis
Part of Bones, joints & muscles clinical trials.
This trial tests a new treatment called 608 for people with a type of spinal arthritis that doesn't show up on X-rays but causes inflammation and back pain. It's a 3-year study to see if the drug can help control symptoms and improve quality of life.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have axial spondyloarthritis diagnosed by a doctor.
- You have signs of active inflammation, like an abnormal MRI or high C-reactive protein in blood.
- You have back pain of at least 4 out of 10 on a pain scale.
- You do not have other active inflammatory diseases, serious infections, or a history of cancer.
- You are not allergic to the trial drug or the spray.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a pain-relief medication called acemetacin works well and is safe for people with axial spondyloarthritis, a type of inflammatory spine condition. Researchers will track your symptoms and side effects over time in a real-world setting.
This study tests a new medicine called 608 for people with non-radiographic axial spondyloarthritis (a type of inflammatory back pain). The goal is to see if it can reduce pain and inflammation.
This study tests a new medication (called 608) for adults with active ankylosing spondylitis (AS). It aims to see if the drug can reduce AS symptoms and improve quality of life.
This trial tests a new oral medication called LNK01001 for adults with active ankylosing spondylitis. It aims to reduce pain, stiffness, and inflammation when standard NSAID treatments no longer help.
This trial tests a new injection called SHR-1314 for people with active non-radiographic axial spondyloarthritis (a type of inflammatory arthritis that doesn't show on X-rays but causes back pain and stiffness). It may help reduce inflammation and improve symptoms.
This trial tests an investigational medication called SCT650C for people with active axial spondyloarthritis. It aims to see if it can reduce pain and inflammation better than current treatments.
Hear when a new Axial Spondyloarthritis, Non-Radiographic trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.